| Gilead Sciences 2nd-qtr profit rises 8.6 pct | | Reuters Health - 17 Hours ago | | LOS ANGELES (Reuters) - Gilead Sciences Inc reported an 8.6 percent increase in second-quarter profit on Thursday, driven by higher sales of its drugs that fight the virus that causes AIDS. But the results | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| Jubilant, Amgen Enter Drug Discovery Deal | | Chemical Week - 17 Hours ago | | Email This Page Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals Lonza to Co-Develop Novartis Biologics Pipeline Riemser | | | | Add Comment |
|
|
|
| Gilead numbers €uninspiring€™ | | FierceBiotech - 17 Hours ago | | TheStreet's Adam Feuerstein rated Gilead Science's second quarter numbers 'uninspiring,' with strong top-line results and a disappointment in earnings. As one of the few profitable biotechs in the market, | | | | Add Comment |
|
|
|
| Still Liking Gilead, Warts and All | | Motley Fool - 18 Hours ago | | After another quarter in the books, it's still tough find much to complain about with drug company Gilead Sciences (Nasdaq: GILD). On Thursday, Gilead posted second-quarter numbers, showing no major cracks | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| MacroGenics acquires Raven Biotechnologies | | Pharmaceutical Business Review - 15 Hours ago | | MacroGenics will issue shares of its stock to purchase Raven. Montgomery & Co served as the financial advisor to Raven. Arnold & Porter served as legal advisor to MacroGenics. Scott Koenig, president | | | | Add Comment |
|
|
|
| |
|
| Security chiefs for biometric control system | | Gulf Times - 16 Hours ago | | THE need to introduce the biometric border-control system at the air and sea ports besides border posts in all the Arab countries was unanimously endorsed by the security chiefs of the Arab countries | | | | Add Comment |
|
|
|
| Greenwood Biotech Firm Names New CEO | | Inside INdiana Business - 17 Hours ago | | Greenwood-based ELONA Biotechnologies, Inc. has named Arthur Patterson as its new chief executive officer. Previous CEO Ron Zimmerman will continue as chairman. Patterson has been executive director of | | | | Add Comment |
|
|
|
| Healthcare 'Safe'? Nobody Told Gilead | | Seeking Alpha - 17 Hours ago | | Another 'safe' sector - healthcare... here you can lose 9% instead of 12% elsewhere aka 'it's safe' ;) GILD) breaks down Great company but nothing is truly safe in the bear. Meanwhile since Citigroup | | | | Add Comment |
|
|
|
| |
|
| |
|
| |
|
| |
|
| Biotech incubator UEL cuts staff | | Twin Cities Business Journal - 16 Hours ago | | Startup incubator University Enterprise Laboratories (UEL) is laying off two employees and outsourcing management its St. Paul headquarters in order to cut costs and focus more on outreach to businesses. | | | | Add Comment |
|
|